Annapolis, MD (PRWEB) January 27, 2023 Metavivor Research and Support Inc., a non-profit organization dedicated to funding research for stage IV metastatic
Preclinical results from Georgetown University support that SM-88 is potentially a novel anti-cancer agent in drug resistant estrogen receptor positive.